摘要
目的对近年来我院收治的结核病人耐多药现状及防治措施进行探讨。方法选取2008年1月至2014年1月期间收治的545例结核病人作为研究对象,对其临床资料进行回顾分析。结果根据初次治疗和再次治疗将患者分为两组,初治组410例,耐药率为16.1%,耐多药率为3.7%,复治组135例,耐药率为25.2%,耐多药率为17.0%,复治组明显高于初治组,差异显著,有统计学意义,P<0.05。结论结核病人耐多药情况较为严重,必须进行结核病控制,保证对耐多药结核病人进行有效、规范的管理,避免耐药菌株繁殖与传播。
Objective In recent years,our hospital for people with MDR- TB status quo and prevention measures were discussed. Methods Select the period from January 2008 to January 2014 in our hospital 545 cases of TB as research subjects,clinical data were retrospectively analyzed. Results According to initial treatment and re- treatment patients were divided into two groups,the initial treatment group 410 cases,resistance rate was 16. 1%,3. 7% MDR,retreatment group of 135 cases,25. 2% resistance rate,MDR rate was 17. 0%,significantly higher than retreatment initial treatment group,significant difference was statistically significant,P〈0. 05. Conclusion Our hospital cases of multidrug- resistant TB is more serious,the need for TB control,to ensure that MDR- TB effective,standardized management,to avoid the breeding and spread of resistant strains.
出处
《医药论坛杂志》
2015年第2期81-82,共2页
Journal of Medical Forum
关键词
结核病
耐多药
防治
Tuberculosis
MDR
Prevention
